Profound Medical (PROF) EBIAT (2024 - 2026)

Profound Medical's EBIAT history runs 3 years deep, the most recent figure standing at -$7.1 million for Q1 2026.

• In Q1 2026, EBIAT rose 34.23% year-over-year to -$7.1 million; the TTM figure through Mar 2026 stood at -$38.9 million (down 21.73% YoY), while the FY2025 annual figure was -$42.6 million, down 53.04% from the prior year.
• EBIAT was -$7.1 million for Q1 2026 at Profound Medical, up from -$8.2 million in the prior quarter.
• In the past five years, EBIAT ranged from a high of -$4.9 million in Q4 2024 to a low of -$15.7 million in Q2 2025.
• Historically, EBIAT has averaged -$8.6 million across 3 years, with a median of -$8.0 million in 2025.
• The sharpest annual moves came in 2025 and 2026: EBIAT sank 126.84% in 2025, then soared 34.23% in 2026.
• A 3-year view of EBIAT shows it stood at -$4.9 million in 2024, then sank by 65.25% to -$8.2 million in 2025, then rose by 13.72% to -$7.1 million in 2026.
• The last three EBIAT figures came in at -$7.1 million (Q1 2026), -$8.2 million (Q4 2025), and -$8.0 million (Q3 2025), per Business Quant data.